DOST-ITDI to pivot backend innovation through its webcast @ Innohub sa Pinas

 

DOST-ITDI to pivot backend innovation through its webcast @ Innohub sa Pinas

The Industrial Technology Development Institute (DOST-ITDI), in its bid to contribute to industrialization and progress through R&D initiatives, will conduct a webcast for its newly opened Modular Multi-Industry Innovation Center (MMIC) or InnoHub sa Pinas on March 31, 2021.



Following MMIC’s successful launch in December 2020 and inauguration in February 2021, ITDI once again invites industry partners and stakeholders to share their insights and expectations about the new facility.

InnoHub sa Pinas is an industrial processing facility with multifunctional/multi-application modular unit operation equipment that can be retrofitted to accommodate different manufacturing lines. It is built to serve the needs of the food, personal care, and pharma-nutraceutical industries using its three main processing lines for nut/seed and oils, mix blend powders, and liquids/emulsions which rely mainly on by-products of commercial operations as raw material. In effect, new or novel products are made out of processing wastes through backend innovation.

Further, InnoHub sa Pinas is open to academe and other interested stakeholders for use in research and development of new products, product equivalent, product variances and product reintroduction.

As one of DOST’s big 20 tickets for 2020, the facility is set to become a one-stop-shop for product conceptualization, development, and marketing, thus collaboration with significant industry and other users is important to sustain efficient services.

It expects that with InnoHub sa Pinas’ modern equipment and devices, as well as experts to lead the operation, previous deficiencies that may hinder advancement in STI will be reduced.

 

(DDGotis\\ DOST- ITDI S&T Media Service)

Comments

Post a Comment

Popular posts from this blog

DOST-ITDI sets MATDEV forum

Image
  The  Industrial Technology Development Institute (DOST-ITDI)  is gathering  industry, academe, government, and non-profit organizations  in a stakeholders' forum to be held on  March 25, 2021 , via the Zoom Meeting platform, to present  MATDEV Laboratory’s current and future activities on additive manufacturing (AM). AM  is the technique being used by the MATDEV Laboratory  to produce models and prototypes  directly from  three-dimensional (3D) computer-aided design (CAD)  without using any tools or fixtures. Funded by the  DOST Grants-In-Aid Program ,  MATDEV Laboratory  is a project under the  Advanced Additive Manufacturing R&D Program. Inaugurated on December 22, 2020, the MATDEV Laboratory undertakes  research and development  on  materials for use in additive manufactured products  to reduce the cost of raw materials by using local resources. However, AM has been in use  ...
Read more

Amcen MATDEV STAKEHOLDERS FORUM HAPPENING NOW United Bloggers Philippines

Image
Today March 25 2021 is the Amcen MATDEV Stakeholders Forum. Glad to be part of it again invited by Ms.Adelia of DOST ITDI . I always love to attend event of DOST ...My very first one is from DOST Pagasa where we had a 2 nights and 3 days stay in a hotel in Cavite  then invitation from DOST ITDI a virtual Inauguration event then this one Amcen is a known as a shared facility between ITDI and the Metals Industry Research and Development Center (DoST-MIRDC). And The second facility inside Amcen is MIRDC's RAPPID-ADMATEC (Research on Advanced Prototyping for Product Innovation and Development using Additive Manufacturing Technologies They  always targets  to reduce cost of the raw materials by using local resources and make sure to increase effective use of AMabled products. MATDEV means Materials Development wherein they innovate to help our economy specially in this pandemic time these is very much needed right now .We need to always advance And make sure we ...
Read more

Suggested headline: FDA approves Sputnik V for Emergency Use

 Press Release: Sputnik V receives FDA’s Emergency Use Authorizati The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Sputnik V, one of Russia’s COVID-19 vaccines, today, 19 March 2021, as announced by FDA Director General Eric Domingo during the Department of Health (DOH)’s Special Briefing. Authorized for limited use among Filipino individuals aged 18 and above, the non-replicating viral vector COVID-19 vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology through the support of the Russian Direct Investment Fund (RDIF). Both Gamaleya and RDIF were identified by the Department of Science and Technology (DOST), which chairs the Task Group on Vaccine Evaluation and Selection (TG VES), as one of its bilateral partners for the possible conduct of vaccine clinical trials in the Philippines. The DOST-convened Vaccine Expert Panel (VEP) has reviewed the initial clinical trial data of Sputnik V, which ser...
Read more